Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1052 | 948 | 1052 | 1161 | 1513 | 2725 |
Fund Return | 5.16% | -5.19% | 5.16% | 5.09% | 8.63% | 10.55% |
Place in category | 196 | 621 | 196 | 8 | 24 | 41 |
% in Category | 18 | 64 | 18 | 1 | 6 | 11 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S Horizon Global Technology Fund Hg | 6.14M | 35.99 | 12.67 | 19.40 | ||
S Horizon Global Technology Fund 1g | 2.58M | 36.09 | 12.75 | 19.64 | ||
S Horizon Global Technology Fund Ag | 27.47M | 34.89 | 11.77 | 18.60 | ||
Opportunities Fund I Inc | 39.07M | -0.71 | 3.78 | 8.50 | ||
Opportunities Fund P Acc | 443.91K | -0.40 | 4.09 | 8.81 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Wellington Global Health Care EquiG | 2.05B | 6.70 | 4.03 | 11.14 | ||
Adamant Medtech I GBP | 1.67B | 10.76 | 0.98 | 12.16 | ||
Global Health Care Fund W Acc GBP | 111.29M | 1.25 | -0.40 | 8.83 | ||
Pharmaceuticals Index Trust F Acc | 264.72K | 3.03 | 1.86 | 9.24 | ||
Pharmaceuticals Index Trust F Dist | 890.37Array | 3.03 | 1.83 | 9.21 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.97 | 785.41 | +2.45% | |
UnitedHealth | US91324P1021 | 6.61 | 532.51 | +0.52% | |
AstraZeneca | GB0009895292 | 3.66 | 11,093.6 | +0.39% | |
Novo Nordisk B | DK0062498333 | 3.66 | 610.9 | -1.85% | |
J&J | US4781601046 | 3.06 | 146.82 | +0.12% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Strong Buy |
Technical Indicators | Strong Buy | Sell | Strong Buy |
Summary | Strong Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review